142 related articles for article (PubMed ID: 1814396)
1. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T
J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease.
Inaguma Y; Shinohara H; Inagaki T; Kato K
J Neurol Sci; 1992 Jul; 110(1-2):57-61. PubMed ID: 1506869
[TBL] [Abstract][Full Text] [Related]
3. [Aging of nervous system and S-100 proteins].
Kato K; Asano T; Inagaki T; Yamamoto T; Sato T
Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):287-92. PubMed ID: 2145454
[TBL] [Abstract][Full Text] [Related]
4. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Gabriel SM; Haroutunian V; Powchik P; Honer WG; Davidson M; Davies P; Davis KL
Arch Gen Psychiatry; 1997 Jun; 54(6):559-66. PubMed ID: 9193197
[TBL] [Abstract][Full Text] [Related]
5. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
Bons N; Mestre N
C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
[TBL] [Abstract][Full Text] [Related]
6. Selective increase in S-100 beta protein by aging in rat cerebral cortex.
Kato K; Suzuki F; Morishita R; Asano T; Sato T
J Neurochem; 1990 Apr; 54(4):1269-74. PubMed ID: 2107276
[TBL] [Abstract][Full Text] [Related]
7. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software].
Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271
[TBL] [Abstract][Full Text] [Related]
8. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
[TBL] [Abstract][Full Text] [Related]
9. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
Sorbi S; Piacentini S; Amaducci L
Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
Hof PR; Cox K; Morrison JH
J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
[TBL] [Abstract][Full Text] [Related]
11. Imidazoline receptor proteins in brains of patients with Alzheimer's disease.
García-Sevilla JA; Escribá PV; Walzer C; Bouras C; Guimón J
Neurosci Lett; 1998 May; 247(2-3):95-8. PubMed ID: 9655601
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Alzheimer's disease-associated protein in Alzheimer's disease frontal and temporal cortex.
Bissette G; Smith WH; Dole KC; Crain B; Ghanbari H; Miller B; Nemeroff CB
Arch Gen Psychiatry; 1991 Nov; 48(11):1009-12. PubMed ID: 1747015
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease.
Davidsson P; Bogdanovic N; Lannfelt L; Blennow K
Dement Geriatr Cogn Disord; 2001; 12(4):243-50. PubMed ID: 11351135
[TBL] [Abstract][Full Text] [Related]
14. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.
Du AT; Schuff N; Kramer JH; Rosen HJ; Gorno-Tempini ML; Rankin K; Miller BL; Weiner MW
Brain; 2007 Apr; 130(Pt 4):1159-66. PubMed ID: 17353226
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains.
Yew DT; Wong HW; Li WP; Lai HW; Yu WH
Neuroscience; 1999 Mar; 89(3):675-86. PubMed ID: 10199604
[TBL] [Abstract][Full Text] [Related]
16. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease.
Hellweg R; Gericke CA; Jendroska K; Hartung HD; Cervós-Navarro J
Int J Dev Neurosci; 1998; 16(7-8):787-94. PubMed ID: 10198825
[TBL] [Abstract][Full Text] [Related]
17. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease.
Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML
Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828
[TBL] [Abstract][Full Text] [Related]
18. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients.
Dedman DJ; Treffry A; Candy JM; Taylor GA; Morris CM; Bloxham CA; Perry RH; Edwardson JA; Harrison PM
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):509-14. PubMed ID: 1445209
[TBL] [Abstract][Full Text] [Related]
19. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
[TBL] [Abstract][Full Text] [Related]
20. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.
Norris PJ; Faull RL; Emson PC
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):36-49. PubMed ID: 8883932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
